RIP140 and LCoR expression in gastrointestinal cancers.

Triki, Mouna; Ben Ayed-Guerfali, Dorra; Saguem, Ines; Charfi, Slim; Ayedi, Lobna; Sellami-Boudawara, Tahia; Cavailles, Vincent; Mokdad-Gargouri, Raja

Triki, Mouna; Ben Ayed-Guerfali, Dorra; Saguem, Ines; Charfi, Slim; Ayedi, Lobna; Sellami-Boudawara, Tahia; Cavailles, Vincent; Mokdad-Gargouri, Raja.

Afiliación

Triki M; IRCM (Institute of Cancer Research of Montpellier), INSERM U1194, Montpellier University, Montpellier, France.
Ben Ayed-Guerfali D; Center of Biotechnology of Sfax, Laboratory of Eukaryotic Molecular Biotechnology, Sfax University, Sfax, Tunisia.
Saguem I; Center of Biotechnology of Sfax, Laboratory of Eukaryotic Molecular Biotechnology, Sfax University, Sfax, Tunisia.
Charfi S; Department of Anatomopathology, Habib Bourguiba Hospital, Sfax, Tunisia.
Ayedi L; Department of Anatomopathology, Habib Bourguiba Hospital, Sfax, Tunisia.
Sellami-Boudawara T; Department of Anatomopathology, Habib Bourguiba Hospital, Sfax, Tunisia.
Cavailles V; Department of Anatomopathology, Habib Bourguiba Hospital, Sfax, Tunisia.
Mokdad-Gargouri R; IRCM (Institute of Cancer Research of Montpellier), INSERM U1194, Montpellier University, Montpellier, France.

Oncotarget ; 8(67): 111161-111175, 2017 Dec 19.

Article en En | MEDLINE | ID: mdl-29340045

Palabras clave

LCoR; RIP140; gastrointestinal cancer; immunohistochemistry; patient survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google